agitg trial news

AGITG Trial News

AGITG Trial news: The AGITG currently has fifteen studies open to recruitment and four studies in follow up.

The table below details the AGITG trials that are currently accruing patients.

Recruited Target Recruitment Period (months) Date of First Site Open (ANZ) Number of Sites Open (ANZ)
ACTICCA-1 17 40 36 25 July 2016 13
ASCOLT 398 400 48 18 June 2014 32
ASCOLT – Global 1460 1587
DYNAMIC-III 309 1000 54 09 October 2017 35
DYNAMIC-Pancreas 13 438 54 01 March 2019 17
DYNAMIC-Rectal 100 408 36 18 June 2018 26
INTEGRATE II 62 90 48 19 October 2016 27
INTEGRATE II – Global 175 350
MASTERPLAN 120 48 01 October 2019 3
MODULATE 80 90 24 13 September 2018 15
MONARCC 14 80 24 20 June 2018 17
NABNEC 36 70 54 15 September 2016 16
NEO-CREATE 3 20 36 November 2019 1
PALEO 1 54 36 16 September 2019 1
RENO 14 250 36 21 January 2019 2
SPAR 30 222 48 13 April 2018 15
TOP GEAR 231 280 118 29 September 2009 20
TOP GEAR – Global 524 570

Recruitment figures are for Australian and New Zealand sites as at end December 2019.

Trial Results Lay Summaries (click on the links below): 
ALaCaRT

ATTACHE
ATTAX-3
GAP
ICECREAM
INTEGRATE
TACTIC
TOP GEAR
CO.17
EORTC 62024
Advanced GIST

Share